IMEGLIMIN

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C6H13N5
Molecular Weight	155.2009
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of IMEGLIMIN

Structure Search

SMILES

C[C@@H]1NC(N)=NC(=N1)N(C)C

InChI

InChIKey=GFICWFZTBXUVIG-SCSAIBSYSA-N

InChI=1S/C6H13N5/c1-4-8-5(7)10-6(9-4)11(2)3/h4H,1-3H3,(H3,7,8,9,10)/t4-/m1/s1

HIDE SMILES / InChI

Molecular Formula	C6H13N5
Molecular Weight	155.2009
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 18:32:34 UTC 2023` Edited by `admin` on `Fri Dec 15 18:32:34 UTC 2023`
Record UNII	UU226QGU97
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

IMEGLIMIN

Official Name

English

imeglimin [INN]

Common Name

English

(4R)-6-(DIMETHYLAMINO)-4-METHYL-4,5-DIHYDRO-1,3,5-TRIAZIN-2-AMINE

Systematic Name

English

EMD-387008

Code

English

Imeglimin [WHO-DD]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29711

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

Code System Code Type Description

PUBCHEM

24812808

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

PRIMARY

INN

8969

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

PRIMARY

EPA CompTox

DTXSID50228237

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

PRIMARY

WIKIPEDIA

Imeglimin

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

PRIMARY

FDA UNII

UU226QGU97

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

PRIMARY

CAS

775351-65-0

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

PRIMARY

DRUG BANK

DB12509

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

PRIMARY

NCI_THESAURUS

C132841

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

PRIMARY

SMS_ID

300000005897

Created by admin on Fri Dec 15 18:32:34 UTC 2023 , Edited by admin on Fri Dec 15 18:32:34 UTC 2023

PRIMARY

Related Record Type Details


					MN7P3P5BYB

IMEGLIMIN HYDROCHLORIDE

SALT/SOLVATE -> PARENT

Amount:


					6NP3XSMIP3

MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1

TRANSPORTER -> SUBSTRATE


					B46KUN2O9L

MATE-2

TRANSPORTER -> SUBSTRATE


					ONY583280Z

OCT-1

TRANSPORTER -> SUBSTRATE


					UU226QGU97

IMEGLIMIN

EXCRETED UNCHANGED

Qualification:

URINE

Amount:


					6NP3XSMIP3

MULTIDRUG AND TOXIN EXTRUSION PROTEIN 1

TRANSPORTER -> INHIBITOR


					UU226QGU97

IMEGLIMIN

EXCRETED UNCHANGED

Comments:

In feces, 14C radioactivity was excreted almost exclusively as unchanged drug, representing 99% of the recovered fecal radioactivity

Qualification:

FECAL

Amount:


					ONY583280Z

OCT-1

TRANSPORTER -> INHIBITOR


					6D53G0FD0Z

PLASMA PROTEIN FRACTION (HUMAN)

BINDER->LIGAND

Comments:

Plasma protein binding was low, which can explain the rapid distribution to organs observed in all species.

Interaction Type:

BINDING

Amount:


					482M00274D

OCT-2

TRANSPORTER -> SUBSTRATE


					482M00274D

OCT-2

TRANSPORTER -> INHIBITOR

Related Record Type Details


					V54B8EP72Z

EMD-90076

METABOLITE -> PARENT


					J447B52DKD

METABOLITE -> PARENT

Qualification:

URINE

Amount:


					R7WCU53XRW

METABOLITE -> PARENT


					AX41T8ULB3

METABOLITE -> PARENT

Related Record Type Details


					UU226QGU97

IMEGLIMIN

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Tmax	PHARMACOKINETIC				SINGLE ORAL ADMINISTRATION

Biological Half-life	PHARMACOKINETIC				SINGLE ORAL ADMINISTRATION